Мақола

Challenges and opportunities in ovarian cancer care: A qualitative study of clinician perspectives from 24 low- and middle-income countries

Anmol BajwaWorld Ovarian Cancer Coalition, Toronto, Canada. Electronic address: [email protected]Runcie C.W. ChidebeProject PINK BLUE - Health & Psychological Trust Centre, Abuja, Nigeria; Department of Sociology & Gerontology & Scripps Gerontology Center, Miami University, Oxford, OH, USA. Electronic address: [email protected]Tracey L. AdamsDepartment of Obstetrics and Gynaecology, Groote Schuur Hospital, Cape Town, SA SA MRC UCT GCRC ( South African Medical Research Centre Gynaecological Cancer Research Centre), South Africa. Electronic address: [email protected]Garth FunstonWolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom. Electronic address: [email protected]Isabelle SoerjomataramCancer Surveillance Branch, International Agency for Research on Cancer+, Lyon, France. Electronic address: [email protected]S. Robin CohenSandy Rollman Ovarian Cancer Foundation, Philadelphia, PA, USA. Electronic address: [email protected]Rafe Sadnan AdelCancer Bangladesh, Founder, Dhaka, Bangladesh. Electronic address: [email protected]Ngoc PhanDa Nang Oncology Hospital, Gynecologic Oncology, Da Nang, Viet Nam. Electronic address: [email protected]Dilyara KaidarovaKazakh Institute of Oncology and Radiology, Almaty, Kazakhstan. Electronic address: [email protected]Raikhan BolatbekovaKazakh Institute of Oncology and Radiology, Almaty, Kazakhstan. Electronic address: [email protected]Basel RefkyMansoura University Hospital, Oncology Centre, Mansoura, Egypt. Electronic address: [email protected]Florencia NollSanatorio Allende Cerro, Gynecologic Oncology Department, Cordoba, Argentina. Electronic address: [email protected]Mary EikenInternational Gynecologic Cancer Society, Head Office, Chicago, USA. Electronic address: [email protected]Martin OrigaUganda Cancer Institute, Gynecologic Oncology, Kampala, Uganda. Electronic address: [email protected]Asima MukhopadhyayChittaranjan National Cancer Institute, Kolkata Gynecological Oncology Trials and Translational Research Group, Kolkata, India. Electronic address: [email protected]Sara NasserCharite University Hospital Campus Virchow Klinikum, Gynecology and Gynecological, Oncology, Berlin, Germany. Electronic address: [email protected]Iren LauPusat Perubatan Universiti Malaya, Obstetrics and Gynaecology, Kuala Lumpur, Malaysia. Electronic address: [email protected]Thomas O. KonneyKwame Nkrumah University Of Science and Technology/Komfo Anokye Teaching Hospital, Kumasi, Ghana. Electronic address: [email protected]Afrin Fatima ShaffiMoi Teaching Referral Hospital, Kenya. Electronic address: [email protected]Precious Takondwa MakondiKamuzu Central Hospital - National Cancer Center, Lilongwe, Malawi. Electronic address: [email protected]Yin Ling WooUniversity of Malaya & ROSE Foundation, Kuala Lumpur, Malaysia. Electronic address: [email protected]Ricardina RangeiroMaputo Central Hospital, Mozambique. Electronic address: [email protected]Aisha MustaphaAhmadu Bello University Teaching Hospital, Zaria, Nigeria. Electronic address: [email protected]Susan MsadabweDepartment of Radiation Oncology, Cancer Diseases Hospital, Lusaka, Zambia. Electronic address: [email protected]Nada BenhimaMedical Oncology Department, Mohammed VI University Hospital, Marrakech 40080, Morocco. Electronic address: [email protected]Nargiza ZahirovaGynecological Oncology Department, Republican Specialized Scientific and Practical Center of Oncology and Radiology, Tashkent, Uzbekistan. Electronic address: [email protected]Carlos Eduardo Mattos Cunha AndradeDepartment of Oncogenetics, Barretos Cancer Hospital, Barretos, Brazil. Electronic address: [email protected]René ParejaDepartment of Gynecologic Oncology, Instituto Nacional de Cancerología, Colombia. Electronic address: [email protected]David Cantú de LeónDirección de Investigación, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: [email protected]Carlos Chávez-ChirinosDepartamento de Cirugía Oncológica, Instituto Regional de Enfermedades Neoplásicas Sur, Arequipa 04000, Peru. Electronic address: [email protected]Ian BamburyDepartments of Obstetrics and Gynaecology and Pathology, University of the West Indies, Mona, Kingston, Jamaica. Electronic address: [email protected]Shahana PervinDepartment of Gynae Oncology, National Institute of Cancer Research and Hospital, Dhaka 1213, Bangladesh. Electronic address: [email protected]Jitendra PariyarGynecologic Oncology Unit, Civil Service Hospital, Kathmandu, Nepal. Electronic address: [email protected]Erick Estuardo EstradaHospital General San Juan de Dios, Gynecology and Obstetrics, Guatemala City, Guatemala. Electronic address: [email protected]Eva-Maria StrömsholmGynecological Cancerpatients in Finland, Espoo, Finland. Electronic address: [email protected]Clara MackayWorld Ovarian Cancer Coalition, Toronto, Canada. Electronic address: [email protected]Phaedra CharltonWorld Ovarian Cancer Coalition, Toronto, Canada. Electronic address: [email protected]Frances ReidWorld Ovarian Cancer Coalition, Toronto, Canada. Electronic address: [email protected]

Journal of Cancer Policyjournal2025en

ABI

Аннотация

BACKGROUND: Ovarian cancer poses a significant and growing burden, particularly in low- and middle-income countries (LMICs) where incidence and mortality are projected to increase by over 50 % by 2050. However, there is a critical lack of qualitative data on the challenges and opportunities for improvement in treatment and care for women with ovarian cancer in these regions. The aim of this research is to investigate clinicians' perspectives on the matter in 24 LMICs. METHODS: As part of the multi-country observational Every Woman Study™ (EWS), semi-structured interviews were conducted with clinicians between June 2022 and June 2023. The interview guide was developed by the EWS LMIC Oversight Committee, including patients, clinicians and data specialists. Relational content and inductive thematic analyses were employed and categories synthesized using the World Health Organization's six building blocks of the Health Systems Framework. RESULTS: 24 clinicians (54 % female; 79 % gynaecologic oncologists, 8 % gynaecologists, 8 % clinical oncologists not specializing in gynaecological cancers, and 4 % clinical oncologists specializing in gynaecological cancers; 42 % from Africa, 29 % from Asia, 29 % from Latin America) participated. Six dominant themes were identified: "Poor Ovarian Cancer Data'', "Inequity in Access to Treatment", "In-Country Inequities in Access to Care", "Role of Cultural Norms on Women's Health", "Increased Engagement of Men in Ovarian Cancer Control", and "Advocacy and Education for Empowering Women". Content analysis revealed system-level challenges such as delayed drug payments, lack of population-based cancer data, and limited imaging facilities. Patient-level challenges included disparities in access to specialists, limited medication affordability, poor symptom recognition, and reliance on alternative treatments. CONCLUSIONS AND POLICY SUMMARY: This study reveals the complexity of ovarian cancer treatment and care in LMICs and the need to mitigate disparities in these regions, underscoring the need for patient-centred, context specific and intersectoral strategies to be considered in cancer planning to improve ovarian cancer care quality and equity in LMICs.

Ҳали таржима қилинмаган

Мавзулар

Ovarian cancer diagnosis and treatment Global Cancer Incidence and Screening Cervical Cancer and HPV Research

Идентификаторлар

DOI: 10.1016/j.jcpo.2025.100582

Иқтибослар ва манбалар

1 та иқтибос 40 та фойдаланилган манба

Кўрсаткичлар — AkademScholar